RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
Margin status >1 mm is a predictor of survival. Question remains how much margin status reflects tumour biology and how much it reflects surgical technique. Likely a combination of the two. https://t.co/uFb1y9D9il
RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
RT @AnnSurgOncol: JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Cen…
JUNE ISSUE: Pathological Margin Clearance and Survival After #Pancreaticoduodenectomy in a US and European Pancreatic Center. https://t.co/8DFOe6rLsn https://t.co/XqFY0IAD0y
RT @TsengJennifer: Great collaborating with our Dutch colleagues to seek increased survival in @PanCAN @MarcBesselink Amsterdam @AnnSurgOnc…
Great collaborating with our Dutch colleagues to seek increased survival in @PanCAN @MarcBesselink Amsterdam @AnnSurgOncol @BIDMChealth @BostonSOAR @The_BMC @BMCSurgery @BUMedicine https://t.co/uom27kuzxk